Drug Database
YP

Ypeginterferon alpha-2b (PegBeron)

✓ Approved

Xiamen Amoytop Biotech Co.ltd · 重组蛋白 · 重组蛋白

什么是 Ypeginterferon alpha-2b?

Ypeginterferon alpha-2b 是一种重组蛋白,由Xiamen Amoytop Biotech Co.ltd研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Subcutaneous Injection。

药物档案

商品名PegBeron
公司Xiamen Amoytop Biotech Co.ltd
药物类别重组蛋白
给药途径Injectable (Others), Subcutaneous Injection
状态Approved

治疗适应症

Ypeginterferon alpha-2b 针对 3 个适应症,涉及 2 个治疗领域。

治疗领域疾病/病症分期
Infections and infestationsHepatitis B✓ Approved
Infections and infestationsHepatitis C✓ Approved
Neoplasms benign, malignant and unspecified (incl cysts and polyps)Essential thrombocythaemiaPhase II

相关研究文献

PubMedMolecular & cellular oncology2026-11-17

Expression and activity of prolactin receptor isoforms in non-malignant and malignant lung cells.

Rico-Luna Anaiza A, González-Sánchez Ignacio I, Almeida-Aguirre Ericka Karol Pamela EKP, Vergara Edgar E et al.

In recent years, the involvement of prolactin (PRL) in different malignancies, such as breast and prostate cancer, has been reported. Recently, prolactin was also proposed as a biomarker for lung cancer, but its molecular mechanisms remain to be explored in this tissue. The aim of this work was to assess the expression of the prolactin receptor (PRLR) and its isoforms, using non-tumorigenic bronchial epithelial (BEAS-2B) cells as a non-malignant model, and A549 and SK-LU-1 cell lines derived from lung adenocarcinoma (LUAD) as a malignant model. Moreover, the STAT5 signaling pathway was analyzed after the administration of PRL, along with its effects on cell viability in these lung cancer cell lines. PRLR expression was assessed by Western blot, RT-PCR, and immunofluorescence, while STAT5 activation was evaluated via Western blot for p-STAT5 detection and immunofluorescence for nuclear translocation. Additionally, cell viability was determined using the MTT assay. We found differential expression of PRLR isoforms at both the mRNA and protein levels. PRLR protein expression was differentially localized in the subcellular compartments of the A549 and SK-LU-1 LUAD cell lines. Furthermore, even at low doses of PRL treatment, an increase in p-STAT5 (a marker of PRLR canonical pathway) and its subsequent translocation to the nucleus were observed in the SK-LU-1 cell line, indicating the activation of this pathway by PRL. Furthermore, we did not observe significant differences in cell viability after PRL administration at low doses; however, treatment with higher doses of PRL increased the cell viability in SK-LU-1 cells at 24 h and in BEAS-2B cells at 72 h. Overall, the results indicate that isoforms of PRLR are expressed in non-tumorigenic and LUAD cells, and that PRL treatment induces STAT5 translocation, suggesting that its effects may be mediated by different PRLR isoforms. However, further studies involving other types of lung cell lines are needed to determine their role in lung pathophysiology.

PMID 43042257
阅读全文 →
PubMedJSES international2026-11-17

Mechanical investigation of the distal acromial tip fusion for reverse shoulder arthroplasty.

Simcox Trevor G TG, DelliCarpini Gennaro G, Chen Cong C, Dzieza Wojciech K WK et al.

Acromial stress fractures are a potentially catastrophic complication of reverse total shoulder arthroplasty (rTSA). Our ability to delineate at risk patients is improving, but treatments that modify risk are limited. The distal acromial tip fusion (DATF) is a procedure performed concomitantly with rTSA, wherein humeral head autograft is used to create an osseous fusion between the undersurface of the anterior acromion and the superior glenoid rim. This may reinforce the anterior acromion process and increase the rigidity of the shoulder suspensory complex. A mechanical study was conducted using osteoporotic sawbones (fourth generation, Sawbones USA). An MTS universal testing machine was used to apply an inferiorly directed axial load to the anterior acromion. Six DATF procedures were performed utilizing grafts fashioned from cancellous foam blocks (Sawbones USA). Six DATF and 6 control scapulae were then affixed to an epoxy testing block and subjected to a load-to-failure assessment. Force was measured in Newtons (N), and displacement distance in millimeters (mm). Key parameters such as stiffness (N/mm), maximum load (N), displacement at maximum load (mm), mode of failure, and fracture pattern were recorded for each model. Statistical comparisons of continuous variables were conducted using two-sided Welch t-tests. DATF group demonstrated a 64% increase in stiffness (59.7 ± 14.6 vs. 36.5 ± 3.2 N/mm, P = .011) and a 111% increase in maximum load to failure (436.9 ± 62.3 vs. 206.9 ± 42.7 N, P < .001) compared to controls. No significant differences in acromion displacement at max load were observed between groups (7.9 ± 3.0 vs. 7.9 ± 2.4 mm, P = .986). Control scapulae exhibited 2 Levy type 2b and 4 Levy type 3 fractures. The DATF group displayed 5 Levy type 2b fractures and 1 Levy type 1 pattern. In the DATF group, construct failure occurred predominantly via screw bending at the graft-coracoid interface (4 models), with a secondary mode involving vertical graft split (2 models). Performance of a DATF at the time of rTSA imparts significantly increased stiffness and maximum load to failure of the acromion from an inferiorly directed axial load when compared to controls. Clinical studies are warranted to demonstrate osseous union and whether this procedure mitigates acromial fracture risk in-vivo.

PMID 43041217
阅读全文 →
PubMedFrontiers in oncology2026-11-17

Targeted alpha therapy for solid tumors: biological rationale, clinical advances, and future perspectives.

Li Qimin Q, Xie Jian J, Chen Fei F, Li Laixiang L et al.

Targeted alpha therapy (TAT) delivers high-linear-energy-transfer radiation over a few cell diameters and is being explored for resistant and microscopic solid-tumor disease. This targeted narrative review evaluates alpha-emitting platforms and clinical evidence by tumor type and development stage, with a focused literature update through 12 October 2026. Unlike broader radiochemistry-centered reviews, we place approved, randomized, early-phase, observational, and preclinical findings in separate evidence tiers. Radium-223 dichloride has randomized survival evidence in symptomatic bone-metastatic castration-resistant prostate cancer, whereas molecularly targeted actinium-225, lead-212, astatine-211, and thorium-227 agents remain investigational in the indications discussed. Updated examples include the 2026 ACTION-1 actinium-225-DOTATATE dosimetry substudy, the 2026 first-in-human astatine-211-MABG study, 2025 lead-212-DOTAMTATE phase II disclosures, and a negative 2025 mesothelin-targeted thorium-227 study. Quantitative outcomes are reported with their study design and limitations rather than interpreted as indirect head-to-head comparisons. Major barriers include isotope supply, incomplete daughter retention, salivary, marrow, and kidney toxicity, spatially heterogeneous target uptake, and uncertainty in patient-specific microdosimetry. We propose practical, imaging-led selection and a priority-ranked translational roadmap.

PMID 43041765
阅读全文 →
PubMedOncology letters2026-11-17

Febuxostat inhibits non-small cell lung cancer cell proliferation under starvation conditions by modulating xanthine oxidoreductase-associated autophagy.

Yao Xin-Huang XH, Shao Ming M, Xu Yi-Wei YW

Febuxostat (FBX), a selective non-purine xanthine oxidoreductase (XOR) inhibitor clinically indicated for hyperuricemia, has recently attracted attention for its potential antitumor properties. Nevertheless, its potential therapeutic efficacy against non-small cell lung cancer (NSCLC) remains to be fully characterized. XOR expression and enzymatic activity were quantified in NSCLC lines (A549 and SK-MES-1) and compared with normal human bronchial epithelial BEAS-2B cells. The effects of XOR and FBX on cell proliferation, migration and invasion were evaluated using the cell counting kit-8, wound-healing and Matrigel-Transwell invasion assays, respectively. Apoptosis and autophagic flux under starvation conditions (FBS-free DMEM) were assessed using Annexin V/SYTOX staining, DCFH-DA, western blotting (p62 and LC3-II) and LysoTracker Red staining. The functional role of autophagy was validated through rescue experiments using the autophagy activator rapamycin. XOR was found to be markedly upregulated and hyperactive in NSCLC cells compared with normal epithelial cells. Small interfering RNA-mediated XOR knockdown attenuated NSCLC cell viability, migration and invasion. Pharmacological inhibition of XOR by FBX likewise impaired proliferative, migratory and invasive capacities, accompanied by marked suppression of autophagic flux. Notably, these antitumor effects were abrogated by rapamycin-induced autophagy activation. The present findings demonstrated that XOR is involved in the metabolic drive of NSCLC progression under nutrient-deprived conditions. Specifically, FBX exerted anticancer effects by blocking XOR-mediated pathways and suppressing protective autophagy, suggesting that repurposing FBX for NSCLC therapy warrants further preclinical investigation.

PMID 43041748
阅读全文 →
PubMedACS medicinal chemistry letters2026-11-17

Novel Substituted Pyrazoles as SARM1 Inhibitors.

Rong Jian J, Liang Steven H SH

This patent discloses a series of pyrazole derivatives as novel sterile alpha and TIR motif containing 1 (SARM1) inhibitors for the potential treatment of SARM1-related diseases, including neurodegenerative disorders. It provides details on the pyrazoles, their preparations, pharmaceutical compositions, and therapeutic applications.

PMID 43041875
阅读全文 →
PubMedHip international : the journal of clinical and experimental research on hip pathology and therapy2026-11-17

Association between cementless femoral stem geometry and early aseptic loosening following primary total hip arthroplasty.

Chi Regina R, Najdawi Jawad J JJ, Nakla Andrew P AP, Burr Rebecca G RG et al.

Aseptic loosening is a significant complication following total hip arthroplasty (THA), particularly in geriatric patients with diminished bone quality. Femoral stem design in cementless primary THA for osteoarthritis (OA) plays a crucial role in mitigating this risk. This study examined the impact of stem geometry on early aseptic loosening. We hypothesised that single-taper (wedge) stems are associated with higher rates of early aseptic loosening. We retrospectively analysed 2952 cementless primary THA procedures at a single institution between November 2013 and December 2021. Patients ⩾ 65 years old who underwent primary THA for OA were included. Patients with preoperative diagnoses of fracture, avascular necrosis (AVN), or bone neoplasia, and those with periprosthetic fracture (PPF) within 90 days of index procedure were excluded. Femoral stems were categorised into 4 groups: (1) single-taper (wedge); (2A) collarless dual- and triple-taper; (2B) collared dual- and triple-taper; and (3) fit-and-fill. 2-year rates of femoral aseptic loosening as well as return to operating room (OR) were assessed. The study consisted of 1000 single-taper stems, 1185 collarless dual- and triple-taper stems, 213 collared dual- and triple-taper stems, and 554 fit-and-fill stems. Single-taper stems had significantly higher rates of aseptic loosening (0.8% vs. 0.2%) and overall return to the OR (2.6% versus 1.1%). Single-taper stems demonstrated higher rates of return to the OR and revision for femoral aseptic loosening during the 2-year postoperative period. Surgeons should consider these findings when selecting femoral stem designs for elderly patients who plan to undergo cementless primary THA.

PMID 43042742
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多Ypeginterferon alpha-2b